Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

Choose the language:

  Homepage
Continue on the current website:  

 

CoLumbo

CoLumbo is an image analysis software that provides analysis from previously acquired DICOM images to support radiologists in viewing and evaluating lumbar spine images.

Inquire Now

Smart logo
  • MSK
  • Stenosis
  • Image Analysis
  • MRI

Global Impact of Low Back Pain on Disability

Low back pain (LBP) has the highest prevalence globally among musculoskeletal (MSK) disorders and is responsible for the highest proportion of disability adjusted life years among MSK disorders.1

  

AI Lumbar Spine MRI Reading and Reporting

CoLumbo is an image analysis software that provides analysis from previously acquired DICOM images to support radiologists in viewing and evaluating spine images. It provides automatic segmentation, automatic measurements, and assessment of findings and their level of suspicion.

 

Patients with leg and/or back pain or other spine related symptoms or conditions may be referred for L-spine MRI. CoLumbo assists radiologists in reading MRI images of the lumbar spine. It provides information on detected findings and abnormalities. The results are reviewed and confirmed by a radiologist.

Arrow

CoLumbo provides diagnostic accuracy for intervertebral disc labeling and detection of clinically relevant degenerative changes.2

Detection

The introduction into practice of CoLumbo improves the prediction of the presence of stenosis and decreases the observer variability in assessing lumbar spinal stenosis severity based on MRI and its relation to cross- sectional spinal canal area.3

Eye

Clinical Assessment of CoLumbo demonstrates its effectiveness in diagnosis of lumbar spinal canal stenosis.3

timer

Radiologists can save an average of almost 3 minutes of interpretation time per MRI lumbar spine scan with the help of Artificial Intelligence (AI).4

timer

In a study, CoLumbo helped radiology residents cut down MRI interpretation time by segmenting, measuring, and classifying images into editable draft reports.5

hand

CoLumbo is designed to assist users in visualizing, measuring and documenting 
out-of-range measurements on MRI. It has the potential to allow for more patients to be examined and help to reduce waiting times and backlogs

Decreasing Costs. Enhancing Visualization. Customization.6

Dollar

CoLumbo could potentially decrease the cost per patient examination when considering the radiologist’s hourly rate.

Eye Icon

CoLumbo’s user interface displays measurements of related tissues, such as vertebral body and disk heights, enhancing the visualization and review process for the user.

triangle

A feature of CoLumbo is the complete customization of suspected pathology threshold levels. If multiple hospitals or imaging centers use the same threshold levels standardization in reporting may be achieved.

Request a demo

Applications Tailored to You

Discover how our tailored service lines and applications can better suit your needs.

Find Out More
    References

    1 Liu S, Wang B, Fan S, Wang Y, Zhan Y, Ye D. Global burden of musculoskeletal disorders and attributable factors in 204 countries and territories: a secondary analysis of the Global Burden of Disease 2019 study. BMJ Open. 2022;12(6):e062183. Published 2022 Jun 29. doi:10.1136/bmjopen-2022-062183

    2 Lehnen N, Haase R, Faber J, et.al. (2021): Detection of Degenerative Changes on MR Images of the Lumbar Spine with a Convolutional Neural Network: A Feasibility Study. Diagnostics. 2021; 11(5):902. 

    3 Georgiev R, Novakova M, Bliznakova K (2023): Clinical Assessment of CoLumbo Deep Learning System for Central Canal Stenosis Diagnostics. EJMO 2023;7(1):42–48

    4 Georgiev R, Novakova M, Bliznakova K (nd): Artificial Intelligence (AI) Reduces Lumbar Spine MRI Reporting Time

    5 Yang YXC, Yee SY, Tan TSE, et al. An artificial intelligence boost to MRI lumbar spine reporting. European Journal of Radiology. 2024;179:111636.

    6 K241211 (CoLumbo). US Food and Drug Administration. Silver Spring, MD, 2024.

    7 SmartSoft Healthcare. Columbo. IFU version 5, dated 2023-10- 24

     

      Admin workload decreased

      Scanslated could potentially save clinician time by reducing imaging-related calls and messages, and streamlining follow-up appointments.7

      Patient Satisfaction

      A study found that increased patient understanding of radiology reports may lead a to better patient experience.8

      Another study published in August 2024 found patient feedback to be overwhelmingly positive and indicated that the Scanslated report may improve patient-centered outcomes in radiology, such as increasing the patient's knowledge or understanding of their health, allowing patients to feel more prepared for conversations with their healthcare providers, as well as reducing patient anxiety.6

      Patient Loyalty

      A study showed that patients showed higher scores of satisfaction with a radiologist that uses a web based interactive report.9

      Research has shown that focusing on the patient experience and partnering with patients in healthcare delivery can improve patient satisfaction, quality of care, and health outcomes.10

      What Customers Are Saying

       

      The application enables identification of small nodules faster and more reliably, particularly for oncological patients.

       

      Terrence Matalon
      MD, Chairman, Diagnostic Radiology at Einstein Medical Center
       

        Legal Mention

        Currently not available within the Calantic Viewer.

          References

          1. Nam liber tempor cum soluta nobis eleifend option congue nihil imperdiet doming

          2. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Magna aliquam erat volutpat tempo molestie vesse

          Legal Mentions

          1. Nam liber tempor cum soluta nobis eleifend option congue nihil imperdiet doming

          2. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Magna aliquam erat volutpat tempo molestie vesse

          LinkedIn LinkedIn

          © 2022, 2023 Bayer

          The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

          BAYER, the Bayer Cross, Radimetrics and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

          This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

           

          Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

           

          You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

          Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

           

          Bayer U.S. | Digital Solutions, 100 Bayer Blvd., Whippany, NJ 07981-0915

           

          Last Updated: September 2023

          © 2022, 2023, 2024 Bayer

          The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

          BAYER, the Bayer Cross, Radimetrics and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

          This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

           

          Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

           

          You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

          Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

           

          Bayer U.S. | Digital Solutions, 100 Bayer Blvd., Whippany, NJ 07981-0915

           

          Last Updated: January 2025

          Bayer Logo
          • United States